CBIH Statistics
Total Valuation
Cannabis Bioscience International Holdings has a market cap or net worth of 6.60 million. The enterprise value is 7.56 million.
| Market Cap | 6.60M |
| Enterprise Value | 7.56M |
Important Dates
The next estimated earnings date is Friday, January 17, 2025.
| Earnings Date | Jan 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cannabis Bioscience International Holdings has 10.56 billion shares outstanding. The number of shares has increased by 9.58% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 10.56B |
| Shares Change (YoY) | +9.58% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 54.65% |
| Owned by Institutions (%) | n/a |
| Float | 4.79B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.38 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.85 |
| EV / Sales | 21.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -643.81% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 177,454 |
| Profits Per Employee | -272,931 |
| Employee Count | 2 |
| Asset Turnover | 8.98 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.00% in the last 52 weeks. The beta is -0.20, so Cannabis Bioscience International Holdings's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -35.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 51.24 |
| Average Volume (20 Days) | 2,068,816 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, Cannabis Bioscience International Holdings had revenue of 354,907 and -545,861 in losses. Loss per share was -0.00.
| Revenue | 354,907 |
| Gross Profit | 309,766 |
| Operating Income | -406,960 |
| Pretax Income | -545,861 |
| Net Income | -545,861 |
| EBITDA | n/a |
| EBIT | -406,960 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 969 in cash and 965,295 in debt, giving a net cash position of -964,326 or -0.00 per share.
| Cash & Cash Equivalents | 969 |
| Total Debt | 965,295 |
| Net Cash | -964,326 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.06M |
| Book Value Per Share | -0.00 |
| Working Capital | -833,354 |
Cash Flow
| Operating Cash Flow | -435,175 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 87.28%, with operating and profit margins of -114.67% and -153.80%.
| Gross Margin | 87.28% |
| Operating Margin | -114.67% |
| Pretax Margin | -153.80% |
| Profit Margin | -153.80% |
| EBITDA Margin | n/a |
| EBIT Margin | -114.67% |
| FCF Margin | n/a |
Dividends & Yields
Cannabis Bioscience International Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.58% |
| Shareholder Yield | -9.58% |
| Earnings Yield | -8.32% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cannabis Bioscience International Holdings has an Altman Z-Score of -202.48. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -202.48 |
| Piotroski F-Score | n/a |